Results 101 to 110 of about 10,864 (278)

Efficacy and Safety of Oxymetazoline 1% Cream for the Treatment of Mild to Moderate Facial Rosacea

Journal of Cosmetic Dermatology, Volume 24, Issue 4, April 2025.
ABSTRACT Introduction Rosacea is a common skin condition that affects the physical and mental health of the patient. The objective of this study was to evaluate the efficacy and safety of oxymetazoline 1% cream, a specific α1A‐adrenoceptor agonist, for the treatment of mild to moderate facial rosacea.
Fatemeh Sajdeh, Aniseh Samadi, Atefeh Naeimifar, Taraneh Yazdanparast, Maryam Ahmadi, Fatemeh Amiri, Martin Kassir, Alireza Firooz, Saman Ahmad Nasrollahi   +8 more
wiley   +1 more source

Glaucoma animal models in rabbits: State of the art and perspectives—A review

Animal Models and Experimental Medicine, Volume 8, Issue 3, Page 429-440, March 2025.
Glaucoma, a visual thief, is characterized by elevated intraocular pressure (IOP) and loss of retinal ganglion cells (RGCs). Selecting suitable animals for preclinical models is of great significance in research on the prevention, early screening, and effective treatments of glaucoma.
Rong Hu, Kai Wu, Jian Shi, Juan Yu, Xiao‐lei Yao   +4 more
wiley   +1 more source

Comparison of Efficacy and Willingness to a 5% Gluconolactone‐Based Topical Serum and Intense Pulsed Light in Mild Erythema of Rosacea: A Paired Control Study

Journal of Cosmetic Dermatology, Volume 24, Issue 3, March 2025.
ABSTRACT Introduction Mild erythema is a common affliction of rosacea. Many methods including drugs and phototherapy (e.g., Intense Pulse Light, IPL) have been tried to alleviate symptoms. Topical applications for enhancing moisturization have also been thought to be of some benefit.
Yiran Peng, Mengping Mao, Ziyang Huang, Huimin Zhao, Ying Li, Dan Jian   +5 more
wiley   +1 more source

Successful Treatment of Complex and Refractory Rosacea Using Platelet‐Rich Plasma Injection Therapy: Case Series and Review of the Literature

Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.
ABSTRACT Background Rosacea is a chronic inflammatory skin disease that affects a notable proportion of the adult population. Platelet‐rich plasma (PRP) has been widely used to treat various inflammatory diseases due to its potent anti‐inflammatory and antibacterial properties.
Xinyue Pang, Lisha Tan, Boyu Zhao, Xiangjun Kong, Huiping Wang, Shuping Hou   +5 more
wiley   +1 more source

Rosácea ocular: revisão [PDF]

, 2012
Rosacea is a prevalent chronic cutaneous disorder with variable presentation and severity. Although considered a skin disease, rosacea may evolve the eyes in 58-72% of the patients, causing eyelid and ocular surface inflammation.
Hofling-Lima, Ana Luisa, Mannis, Mark J, Vieira, Ana Carolina Cabreira   +2 more
core   +7 more sources

30% Supramolecular Salicylic Acid Improved Symptoms and Skin Barrier in Papulopustular Rosacea

Journal of Cosmetic Dermatology, Volume 24, Issue 2, February 2025.
ABSTRACT Background Rosacea is a chronic skin condition that affects millions of people worldwide, and its management continues to pose a significant challenge in dermatology. Aim In this study, we investigated the efficacy and safety of 30% supramolecular salicylic acid (SSA) as a treatment for papulopustular rosacea, with a particular focus on ...
Zihan Wang, Yutong Wu, Fatemeh Nozzari Varkani, Xian Su, Ziping Yang, Xinghua Gao, Li Zhang   +6 more
wiley   +1 more source

Soluble Guanylate Cyclase α1–Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma [PDF]

, 2013
Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved in the pathogenesis of POAG remains unknown.
Abernathy, Emma, Alt, Clemens, Arora, Pankaj, Bloch, Kenneth Daniel, Brouckaert, Peter, Buys, Emmanuel, Clerté, Maeva, de Waard, Nadine, Giani, Andrea, Gong, Haiyan, Gregory, Meredith S., Hayton, Sarah R., Jones, Alexander, Kang, Jae Hee Hee, Ko, Yu-Chieh, Ksander, Bruce R., Lin, Charles P., Loomis, Stephanie J., Malhotra, Rajeev, Nathan, Daniel, Oh, Dong-Jin, Pasquale, Louis, Ren, Ruiyi, Rhee, Douglas J, Scherrer-Crosbie, Marielle, Tainsh, Laurel T., Tainsh, Robert Edward Tillinghast, Turcotte, Raphael, Wiggs, Janey Lee, Yu, Binglan   +29 more
core   +5 more sources

The Future of Nanomaterials Tackling the Challenge of Delivering Nucleic Acids to the Retina

Advanced Functional Materials, Volume 35, Issue 3, January 15, 2025.
Gene therapy is often the only hope for a cure for many retinal diseases. However, due to the unique anatomy of the eye, the introduction of such genes or nucleic acids is extremely challenging. This article presents various diseases, barriers, and challenges as well as methods and different nanomaterials that are used to deliver nucleic acids into the
José Hurst, Friederike Adams, Sven Schnichels   +2 more
wiley   +1 more source

Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons

Molecular Neurodegeneration, 2011
Background Brimonidine is a common drug for lowering ocular pressure and may directly protect retinal ganglion cells in glaucoma. The disease involves early loss of retinal ganglion cell transport to brain targets followed by axonal and somatic ...
Crish Samuel D, Ruiz Lupe, Lambert Wendi S, Wheeler Larry A, Calkins David J   +4 more
doaj   +1 more source

A New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant

American Journal of Medical Genetics Part A, Volume 197, Issue 1, January 2025.
ABSTRACT Doyne honeycomb retinal dystrophy (DHRD), also termed malattia leventinese (MLVT), is a dominantly inherited ocular disease characterized by the progressive accumulation of macular and peripapillary drusenoid material beneath the retinal pigment epithelium in the Bruch membrane.
Oscar F. Chacon‐Camacho, Thania Ordaz‐Robles, Marion A. Cid‐García, Olivia Yepes‐Rodríguez, Rocio Arce‐González, Alan Martínez‐Aguilar, Juan Carlos Zenteno   +6 more
wiley   +1 more source